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Summary
Activated virus-specific CD8 T cells remain in the lung
airways for several months after influenza virus infec-
tion. We show that maintenance of this cell population
isdependentupon the routeof infectionandprolonged
presentation of viral antigen in the draining lymph
nodes (DLN) of the respiratory tract. The local effects
onTcellmigrationhavebeenexamined.Weshowreten-
tion of virus-specific CD8 T cells in the mediastinal
lymphnode (MLN) and continuing recruitment of blood-
bornemigrants into the lungairwaysduringantigenpre-
sentation. These data show that antigen that is retained
after pulmonary influenza virus infection controls the
migratory pattern and activation state of virus-specific
CD8 T cells near the site of virus amplification.
Introduction
Cytotoxic T cells (CTL) play an important role in clear-
ance of influenza and other respiratory virus infections
and can provide short-term protective cellular immunity
against recurrent illness with a new serotype (Nguyen
et al., 1999, 2001; Topham et al., 1997; Webby et al.,
2003). Curiously, this heterosubtypic protection declines
over the course of a few months (Liang et al., 1994) even
though large numbers of virus-specific CD8 T cells con-
tinue to circulate through the lungs and other organs of
the infected animals for at least 2 years (Doherty et al.,
1996). The reason for the rapid decline in cellular immu-
nity is unclear, although the disappearance of antigen-
specific CD8 T cells from the lung airways is believed
to contribute (Hogan et al., 2001a; Ostler et al., 2001;
Woodland et al., 2002; Ray et al., 2004). It has been es-
tablished that T cells that are transferred into the lung air-
ways can promote viral clearance (Hogan et al., 2001b).
In another study, protection declined when CD8 T cell mi-
gration to the airways was inhibited after viral infection
(Ray et al., 2004).
The mechanisms that control T cell migration to the
lungs are poorly defined; however, it is clear that some
level of T cell activation and/or inflammation of the lungs
is essential for virus-specific CD8 T cells to remain in the
airways by a process that is assisted by integrin VLA-1
(Ray et al., 2004). Small numbers of bystander CD8 T
cells also enter the lung airways during heterologous re-
spiratory infections and other conditions of nonspecific
inflammation (Ely et al., 2003a; Stephens et al., 2002),
but whether these T cell populations are maintained or
*Correspondence: lcauley@uchc.edureplenished later in the response has not been investi-
gated. The virus-specific CD8 T cells that can be isolated
from the lung airways after influenza virus infection are
distinct from the virus-specific memory CD8 T cells in
other tissues, including the lung parenchyma. A large
percentage of these T cells express markers that are
characteristically found on recently activated effector
T cells, such as CD69 and CD25 (Marshall et al., 2001;
Hogan et al., 2001a; Ostler et al., 2001). Our studies show
that these T cells also lack IL-7R expression, which is an-
other indication of recent antigen stimulation (Lang et al.,
2005; Schluns et al., 2000). Together, these data suggest
that a prolonged effector T cell response may be respon-
sible for the chronic activation of virus-specific CD8 T
cells in the lung airways. A recent study showed that in-
fluenza antigens were presented to CD4 T cells up to 4
weeks after infection (Jelly-Gibbs et al., 2005). A small
number of the responding CD4 T cells survived to be-
come resting memory T cells. The possibility that persis-
tent antigen presentation is required for sustained cellu-
lar immunity has been suggested in other viral models
(Gray, 2002; Kundig et al., 1996), but a link between the
activated phenotype of memory T cells in the airways
and the mechanisms that control local T cell migration
have yet to be defined. Here, we have investigated the in-
fluence of antigen presentation on the migration of virus-
specific memory CD8 T cells to the lungs and DLN of the
respiratory tract during declining cellular immunity. Our
studies show that influenza virus antigens, which are re-
tained in the DLN of the respiratory tract, are presented
to CD8 T cells for at least 2 months after infection. At
the same time, the CD8 effector T cell population in the
lung airways continues to be replenished by migrating
T cells in the circulation. These data show that prolonged
antigen presentation in the MLN helps to maintain acti-
vated CD8 T cells near the site of virus amplification in
the lungs, where they can respond rapidly to secondary
viral challenge.
Results
The Route of Infection Controls T Cell Activation
in the Lung Airways
Virus-specific CD8 T cells that express CD69 have been
detected in the lung airways for up to 3 months after in-
fluenza or other respiratory virus infections (Hogan
et al., 2001a; Ostler et al., 2001; Marshall et al., 2001). In
these studies, the CD69+ phenotype was stable, but
the numbers of virus-specific CD8 T cells in the lung air-
ways decreased with time. CD69 is typically induced by
TcR signaling, although some cytokines can also upre-
gulate CD69 expression on T cells (Kranzer et al., 2000;
Sun and Sprent, 2000). As an additional indicator of
TcR-mediated activation, we analyzed IL-7R (CD127)
expression, because this receptor is expressed by naive
T cells and resting memory T cells but is downregulated
after activation (Schluns et al., 2000; Kaech et al., 2003;
Huster et al., 2004; Lang et al., 2005). Virus-specific
CD8 T cells were identified with the NP366–374/D
b tetra-
mer (Flynn et al., 1998) after i.n. HKx31 infection
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440(Townsend and Skehel, 1984). Bronchoalveolar lavage
(BAL) cells were collected on days 40 and 70 after infec-
tion, and lymphocytes were isolated from the perfused
lung tissues (lung parenchyma) by collagenase diges-
tion. On day 40 after viral infection, w15% of the BAL
and w4% of the lung parenchyma CD8+ T cells were
tetramer positive, which included 62% and 18% CD69+
IL-7R2 cells, respectively, indicating the presence of ac-
tivated T cells (Figure 1A). A large percentage of virus-
specific CD8 T cells that remained in the lung airways
after Sendai virus infection was recently shown to ex-
press CD11a at low levels (Ely et al., 2003b; Masopust
et al., 2004). We found similarly low levels of CD11a ex-
pression on a large percentage of the virus-specific T
cells in the BAL so that by day 44 after HKx31 infection
only 10% of the NP366–374/D
b-specific cells expressed
CD11a at the levels found on antigen-experienced T cells
in other tissues (Figure S1 available in the Supplemental
Data with this article online). By day 70, the size of the
NP366–374/D
b-specific CD8 T cell population in the BAL
had greatly decreased, but 46% of the cells remained
CD69+ and IL-7R2. These cells were no longer detect-
able in BAL at 4 months after infection (data not shown).
In order to determine if a direct infection of the lungs
was required to generate activated T cells in the lung air-
ways, mice were infected with HKx31 i.p. and analyzed
30 days later. Substantial numbers of virus-specific
CD8 T cells were detected in the spleens and the lung
parenchyma (data not shown), but not the airways with-
out further treatment (Figure 1B, control). To analyze the
effect of inflammatory signals on the recruitment and ac-
tivation of virus-specific CD8 T cells in the airways, we
used oligodeoxynucleotide (ODN)-DNA (Chang and Bra-
ciale, 2002). Mice that had been infected with HKx31 i.p.
were treated 30 days later with CpG or control ODN-DNA
in the lungs. Three days after CpG ODN-DNA treatment,
large numbers of CD8 T cells, were detected in the BAL,
including NP366–374/D
b-specific cells (Figure 1B), which
were mostly CD69+ and IL-7R+. Elevated numbers of
NP366–374/D
b-specific CD8 T cells were also detected
in the lung airways on day 9 after treatment, as com-
pared to the control mice, but these cells had lost
CD69 expression and remained IL7R+, indicating that
they were resting memory cells (Figure 1B). This showed
that the lung environment was not sufficient for chronic
T cell activation. In another model, OVA-specific mem-
ory CD8 T cells that were generated during a systemic
infection with a recombinant Listeria monocytogenes
expressing chicken ovalbumin (LM-OVA) entered the
lung airways after treatment with CpG-ODN DNA. These
cells also transiently expressed CD69 but did not down-
regulate IL-7R expression (data not shown). It is likely
that the indirect effects of cytokines (type 1 interferons)
that are released during CpG ODN-DNA treatment (Sun
and Sprent, 2000; Kranzer et al., 2000) were responsible
for the transient CD69 expression in these experiments.
These results showed that nonspecific inflammation
of the lungs was not sufficient to maintain the CD69+
IL-7R2 phenotype of the influenza virus-specific CD8 T
cells in the airways.
We used a dual infection model to determine whether
OVA-specific CD8 T cells could persist in the airways of
influenza virus-infected lungs after nonspecific recruit-
ment. Mice that had been infected with LM-OVA 30days earlier were given a pulmonary HKx31 infection.
During the recovery phase of the response to the influ-
enza infection, the mice were divided into two groups
and maintained on BrdU water either 0–10 or 30–40
days after infection. Each group of mice was analyzed
for OVA and NP366–374/D
b-specific CD8 T cells at the
end of the BrdU treatment (Figure 1C).
Mice that have been infected systemically with
LM-OVA typically have less than about 104 lymphocytes
in the lung airways, which include only very small num-
bers of antigen-specific CD8 T cells (Figure S2C). By
the peak of the response to HKx31 infection (day 10),
there were large numbers of NP366–374/D
b-specific CD8
T cells in the BAL, as well as some OVA-specific cells,
that were recruited by nonspecific inflammation (Ely
et al., 2003a; Stephens et al., 2002). A majority of the
NP366–374/D
b-specific CD8 T cells were activated (Fig-
ure S2A) and BrdU+ (Figure 1C), showing that they had
undergone cell division in response to viral infection
(left panels). In contrast, most of the OVA-specific cells
were CD692 IL-7R+ (Figure S2B) and BrdU2, indicating
substantial bystander recruitment to the lung airways
but very little proliferation. There were still large num-
bers of NP366–374/D
b-specific CD8 T cells in the lung air-
ways on day 40, but the frequency of OVA-specific T
cells had decreased almost 10-fold, leaving insufficient
numbers of cells for BrdU analysis (right panels). These
data showed that although bystander memory CD8 T
cells were recruited into the lung airways during acute
influenza virus infection, they were not maintained later
in the response.
Blood-Borne Migrants Replenish Activated Airway
T Cell Populations after Influenza Virus Infection
The data shown in Figure 1 indicated that antigen-spe-
cific memory CD8 T cells did not enter the lung airways
without local infection or inflammation (Figure 1). To de-
termine whether pulmonary influenza virus infection
promoted continuing recruitment of antigen-specific
CD8 T cells into the airways after viral clearance, we uti-
lized parabiotic mice to analyze CD8 T cell migration
(Donskoy and Goldschneider, 1992; Klonowski et al.,
2004).
CD45.2+ C57BL/6 mice were infected i.n. with HKx31
influenza virus. One month later, when the response to
acute viral infection had resolved, each mouse was
joined to an uninfected congenic CD45.1+ partner as de-
scribed previously (Donskoy and Goldschneider, 1992;
Klonowski et al., 2004). The joined pairs were maintained
for 1–3 weeks and then analyzed for NP366–374/D
b-spe-
cific CD8 T cells in the lymphoid and nonlymphoid tis-
sues. Others have shown that joined mice develop
a shared blood supply in a matter of days, allowing cir-
culating lymphocytes to pass freely in the blood be-
tween the infected and uninfected partners (Klonowski
et al., 2004). By day 8 after surgery, the NP366–374/D
b-
specific CD8 T cells had completely equilibrated in the
spleens (Figure 2A) and most other lymphoid organs
(data not shown) of the infected and uninfected part-
ners. In contrast, much slower rates of T cell equilibra-
tion were detected in the lung parenchyma, where on
day 15 there were only half as many NP366–374/D
b-spe-
cific CD8 T cells in the uninfected mice, as compared
to the influenza virus-infected partners (Figure 2B).
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441Figure 1. Route of Infection Controls T Cell
Activation in the Lung Airways
(A) C57BL/6 mice were given 300 EID50
HKx31 influenza virus by i.n. infection. On
days 40 and 70 after infection, NP366–374/D
b-
specific CD8 T cells in the BAL and paren-
chyma (Lung) were counted and analyzed
for CD69 and IL-7R expression. Percentages
of NP366–374/D
b-specific cells within the total
CD8 T cell populations are shown.
(B) Mice were given 5000 EID50 HKx31 influ-
enza virus by i.p. injection. One month later,
the mice were treated with 15 mg CpG or con-
trol ODN-DNA in the lungs. Gated popula-
tions of NP366–374/D
b-specific CD8 T cells
were analyzed for CD69 and IL-7R expression
on days 3 (left) and 9 (right) after ODN-DNA
treatment.
(C) Mice were primed with LM-OVA i.v. and 1
month later infected with HKx31. Groups of
five mice were fed with BrdU water between
days 0 and 10 or 30 and 40 after infection.
Lymphocytes from the BAL and lung paren-
chyma were analyzed for NP366–374/D
b- and
OVA-specific CD8 T cells at the end of
the BrdU treatment. Overlaid histograms
show BrdU content in gated populations of
NP366–374/D
b- (dashed lines) and OVA-
specific (continuous lines) CD8 T cells. Error
bars represent the SEM from five mice.
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after surgery (Figure 2B). Very similar results were ob-
tained when both partners were infected with HKx31 in-
fluenza virus (Figure S3A). There was also a small differ-
ence in the ratio of the total donor and recipient CD8 T
cell populations in the lungs (Figure S3B), indicating
that other virus-specific CD8 T cells, in addition to the
NP366–374/D
b-specific cells, were in disequilibrium on
day 15 after surgery. These results were in contrast to
the migration kinetics of virus-specific CD8 memory T
cells after systemic infection with vesicular stomatitis vi-
rus (VSV), where the antigen-specific cells equilibrated
in the lungs and spleens by day 8 after surgery (Klonow-
ski et al., 2004).
We used different combinations of parabiotic mice to
determine what conditions were necessary for virus-
specific CD8 memory T cells to reach the lung airways.
First, CD45.2+ influenza (day 30) memory mice were
joined to uninfected CD45.1+ partners and analyzed 15
days later. Even though substantial numbers of
CD45.2+ NP366–374/D
b-specific CD8 T cells reached the
lung parenchyma of the uninfected mice, very few en-
tered the airways (Figure 3A). Other CD45.2+ influenza
memory mice (day 30) were joined to CD45.1+ mice
that had also been infected with HKx31 i.n. 30 days pre-
viously. There were large numbers of NP366–374/D
b-spe-
cific CD8 T cells in the BAL of all the animals on day 15
after surgery, of which 19% were partner-derived T cells
(Figure 3B), directly showing that a prior pulmonary in-
fluenza virus infection was sufficient to promote con-
tinuing recruitment of small numbers of virus-specific
CD8 T cells into the airways. The percentage of part-
ner-derived NP366–374/D
b-specific CD8 T cells that ex-
pressed CD11a at high levels in the BAL was consider-
ably larger than the percentage of self-derived cells
that expressed this marker (Figure 3C). Evidence sug-
gests that CD11a expression declines soon after T cells
arrive in the lung airways (Ely et al., 2006), indicating that
some self-derived T cells arrived in the airways before
surgery and persisted for the duration of the experiment.
To further analyze the specificity of the recruitment to
the lung airways, CD45.2+ influenza memory mice were
joined to CD45.1+ mice that had been infected with
LM-OVA 1 month previously. Fifteen days after surgery,
each partner was analyzed for NP366–374/D
b-specific
and OVA-specific CD8 T cells in the lungs (Figure 3D).
Both partners had large numbers of OVA-specific CD8
Figure 2. Different Rates of T Cell Equilibration in Lymphoid and
Nonlymphoid Tissues
C57BL/6 mice were given 300 EID50 HKx31 i.n. and 1 month later
were joined to uninfected CD45.1+ partner animals. The total number
of NP366–374/D
b-specific CD8 T cells in the (A) spleens and (B) lungs
are shown with standard errors from five pairs of mice.T cells in the lung parenchyma, which had reached equi-
librium by day 15 after surgery. The influenza-specific T
cells were much slower to reach equilibrium, with half
as many NP366–374/D
b-specific CD8 T cells in the lung pa-
renchyma of the LM-OVA-infected mice on day 15, as
compared to the HKx31 infected donors. This was very
similar to the pattern seen when HKx31-infected mice
were joined to uninfected partners in Figure 3A and again
suggested that some virus-specific T cells were retained
in the parenchyma after influenza virus infection. Al-
though large numbers of OVA-specific CD8 T cells en-
tered the lung parenchyma of the partner mice (Fig-
ure 3D, right panels), very few cells reached the lung
airways, similar to Figure 1C. Together, these data indi-
cated that continuing recruitment and retention of vi-
rus-specific CD8 T cells into the lung airways was depen-
dent on pulmonary viral infection and appeared to be
antigen specific.
Processed Viral Antigens Persist In Vivo
after Pulmonary Influenza Virus Infection
Despite the fact that influenza virus is considered to be
an acute infection, the CD69+ IL-7R2 phenotype (Fig-
ure 1) and selective recruitment of virus-specific CD8 T
cells into the lung airways (Figure 3) were suggestive
of a continuing response to residual viral antigens. To di-
rectly assay for processed T cell antigens in vivo, we
transferred CFSE-labeled CD45.1+ RAG2/2 TcR trans-
genic CD8 T cells that are specific for the NP366–374/D
b
epitope (F5) (Moskophidis and Kioussis, 1998) to
CD45.2+ mice that had previously been infected with
the E61-13-H17 influenza virus (Townsend and Skehel,
1984). The E61-13-H17 virus was used because it differs
from HKx31 by two amino acids at residues 372 and 373
in the NP epitope (Townsend et al., 1986), which are es-
sential for its recognition by F5 CD8 T cells. All the other
components of the two viruses are identical. Eight days
after transfer, CD45.1+ T cells were analyzed for cell di-
vision by CFSE-dilution (Figure 4). Control mice were un-
infected or infected with HKx31.
FACS analysis showed large numbers of transgenic
CD8 T cells that had initiated proliferation in the lungs
and MLN of the E61-13-H17-infected recipient mice,
but not the control animals (Figure 4A). Some CFSE-
dull cells were also present in the spleens but may
have been the progeny of cells that divided before mi-
grating to this tissue. Other F5 T cells were transferred
to mice 60 days after E61-13-H17 infection and also ini-
tiated cell division in the lungs and MLN (Figure 4A).
These data indicated that processed T cell antigens
were still present in the tissues of the influenza virus-in-
fected recipient mice 2 months after transfer. In both ex-
periments, the highest frequencies of proliferating CD8
T cells were detected in the MLN, suggesting that this
may be an important site of antigen presentation. To de-
termine exactly where T cells were activated, CFSE-la-
beled T cells from F5 mice were used in a transient trans-
fer system using E61-13-H17-infected CD45.2+ recipient
mice as in the previous experiment (Figure 4B). Twenty
hours after transfer, lymphocytes were recovered from
the tissues of the recipient mice and placed in culture
for 3 days at 37ºC with r-IL2. This time interval was se-
lected to allow T cell activation in situ, without subse-
quent migration. After culture, relatively small numbers
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443Figure 3. Influenza Virus-Specific, but Not Bystander, CD8 Memory T Cells Continuously Migrate to the Lung Airways
(A and B) C57BL/6 mice were infected with HKx31 and 1 month later were joined to congenic CD45.1+ partner animals that were either (A) un-
infected or (B) primed with HKx31 i.n. On day 15 after surgery, five pairs of mice were analyzed for self- and partner-derived NP366–374/D
b-specific
CD8 T cells in the BAL and lung parenchyma. (A) and (B) show CD8 gate showing percentages of NP366–374/D
b-specific cells from the partner
animals. The arrows denote the direction of T cell migration.
(C) Joined mice that were both infected with HKx31 were analyzed for CD11a expression on NP366–374/D
b-specific cells in the lung airways. The
CD45.1 marker was used to distinguish partner (continuous line) and self-derived (dashed line) NP366–374/D
b-specific CD8 T cells in each animal.
In (A), (B), and (C), error bars represent the SEM from five pairs of mice.
(D) LM-OVA-infected mice were joined to HKx31-infected partners. Each animal was analyzed for OVA- (right) and NP366–374/D
b-specific (left)
CD8 T cells in the BAL and lung parenchyma.of undivided F5 T cells were detected in the samples
from the control mice, as well as the lungs, pLN, and
spleens of the infected animals. However, greatly ex-
panded populations of F5 T cells were detected in the
CLN and MLN. This indicated that the DLN were the pri-
mary site of sustained antigen presentation. Very similar
results were obtained when CFSE-labeled T cells from
OTI mice (Hogquist et al., 1994) were transferred to re-
cipient animals that had been infected with WSN-OVA1
influenza virus (data not shown), which encodes the
SIINFELK epitope in the neuraminidase stalk influenza
virus (Topham et al., 2001).A potential explanation for the persistence of pro-
cessed T cell antigens in vivo was a chronic viral infec-
tion. To investigate this possibility, we used RT-PCR to
assay for viral RNA on days 6 (acute) and 30 (chronic)
postinfection. Viral RNA that encoded the NP epitope
was detected in the lungs and MLN on day 6 after viral
infection but had dropped below the level of detection
by day 30 (Figure 4C). Very similar results were obtained
by using primers for viral RNA encoding the Matrix
protein (data not shown). The lower intensity of the NP
fragment in the MLN on day 6 most likely reflects the re-
quirement for host protease for virus amplification.
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444Figure 4. Residual Viral Antigens Persist In Vivo for at Least 2 Months after Influenza Virus Infection
(A) E61-13-H17-infected and control mice received 23 106 CFSE-labeled CD45.1+ CD8 T cells from the F5-RAG2/2 mice by i.v. injection on day
30 (left) or 60 (right) after infection. Eight days after transfer, the NP366–374/D
b-specific CD8 T cells in the lungs, MLN, and spleens were analyzed
for CD45.1 expression and CFSE intensity. Gated populations of CD45.1+ NP366–374/D
b-specific CD8 T cells are shown. Marked regions indicate
the percentages of F5 cells that underwent two or more cell divisions after transfer.
(B) C57BL/6 mice were infected with E61-13-H17 and 1 month later received 2 3 106 CFSE-labeled CD45.1+ RAG2/2 F5 cells by i.v. injection.
Lymphocytes were isolated from the recipient lungs, inguinal LN, CLN, MLN, and spleens 20 hr after transfer. Lymphocytes were cultured
for 3 days in IL-2-supplemented media (20 U/ml). Gated population of CD45.1+ CD8 T cells are shown. Peptide NP366–374 was used as a positive
control for cell proliferation.
(C) RNA was extracted from the MLN (M), lungs (L), and inguinal lymph nodes (I) from uninfected and E61-13-H17-infected mice 6 (acute) or 33
(memory) days previously. NP and b-actin fragments were amplified from cDNA by PCR. NP expression was detected in the lungs and MLN of
acutely infected mice, but not the uninfected controls or memory mice. Multiple experiments gave similar results.Because this protease is only present in epithelial cells
of the respiratory tract, influenza infections are largely
restricted to the lungs where virus amplification takes
place. Together, these results suggest that viral anti-
gens were retained in the tissues for an extended period
of time without virus amplification, although it is also
possible that very tiny quantities of virus, which werebelow of detection by PCR, may have been retained in
some tissues.
Virus-Specific CD8 T Cells Are Retained in the MLN
after Influenza Virus Infection
Our data showed that the MLN and CLN were important
sites of antigen presentation during the chronic stage of
T Cell Activation and Migration in the Lung
445the response to pulmonary viral infection. We have found
that the MLN of influenza virus-infected mice remain de-
tectably enlarged for at least 6 months after infection
(data not shown). We therefore wished to determine
whether the presence of processed viral antigens in the
MLN affected the migration of virus-specific CD8 T cells
in the circulation during parabiosis. CD45.1+ and
CD45.2+ congenic partner mice were infected with
HKx31 influenza virus and joined 1 month later. Fifteen
days after surgery (i.e., 45 days after viral infection), the
numbers of self- and partner-derived NP366–374/D
b-
specific CD8 T cells had reached equilibrium in the pLN
(Figures 5A and 5B) and spleens of the joined mice
(data not shown), which was consistent with the migra-
tion kinetics of resting memory CD8 T cells in an earlier
study (Klonowski et al., 2004). In contrast, there was sig-
nificant disequilibrium in the numbers of NP366–374/D
b-
specific CD8 T cells in the MLN, where 80%–90% of the
NP366–374/D
b-specific cells were self-derived CD8 T cells
that had not entered the circulation (Figures 5A and 5B).
This disequilibrium only applied to the virus-specific CD8
T cells because the total numbers of donor and self-
derived CD8 T cells in the MLN of each of the partnered
mice were approximately equal (Figure S3). These find-
ings demonstrated selective retention of virus-specific
CD8 T cells in the MLN during antigen presentation.
Figure 5. Virus-Specific CD8 T Cells Are Retained in the MLN after
Influenza Virus Infection
CD45.2+ C57BL/6 and congenic CD45.1+ partner animals were in-
fected with HKx31 influenza virus and joined 1 month later. On day
15 after surgery, five pairs of mice were analyzed for partner and
self-derived NP366–374/D
b-specific CD8 T cells in the MLN and other
pLN with the CD45.1 and CD45.2 markers.
(A) Gated populations of CD8 T cells with percentages of
NP366–374/D
b -specific cells from the partner animals are shown.
(B) The numbers of self- and partner-derived NP366–374/D
b-specific
CD8 T cells in the MLN and other pLN with SE from five pairs of mice.
Error bars represent the SEM from five pairs of mice.Resting Memory Cells Comprise the Majority
of Migrating CD8 T Cells
Our parabiosis studies showed continuing recruitment
of virus-specific CD8 T cells into the lung airways after
infection, but it was unclear whether these blood-borne
migrants included activated T cells or whether the newly
arrived cells became activated upon entry to the lungs.
To test this, we employed two recombinant influenza vi-
ruses that differ at a single T cell epitope. The WSN-
OVA1 virus expresses the SIINFEKL epitope in the stalk
of the neuraminidase protein (Topham et al., 2001). A
variant of this virus, WSN-OVA0, has a point mutation
in one of the peptide anchor residues of the OVA epitope
(J.A. Hollenbaugh and R.W. Dutton, unpublished data)
that prevents an OVA-specific CD8 T cell response.
CD45.2+ mice were infected with WSN-OVA1 and 1
month later joined to CD45.1+ partners that had been in-
fected with either WSN-OVA0 or WSN-OVA1 (Figure 6).
Three weeks after surgery, OVA-specific CD8 T cells in
the lungs and MLN of the donor and recipient mice were
analyzed for CD69 and IL-7R expression. Between 50%
and 60% of self-derived OVA-specific cells in the lungs
of WSN-OVA1-infected mice were CD69
+ and included
25% with reduced IL-7R expression (Figure 6A, left).
Less than 5% of the OVA-specific cells that migrated to
the lungs and MLN of the WSN-OVA0-infected partners
expressed CD69, with a majority expressing a resting
CD692 IL-7R+ memory phenotype (Figures 6A and 6B,
right panels). Activated self-derived NP366–374/D
b-spe-
cific cells were detected in all the animals, showing that
a productive infection had occurred (data not shown).
When both partners were infected with the WSN-
OVA1, only a small percentage of OVA-specific CD8 T
cells expressed CD69 in the lungs after migration
(w7%), even though both partners expressed the SIIN-
FEKL epitope (Figure 6C). Analysis of the NP and PA epi-
topes gave almost identical results (data not shown).
This frequency of activated T cells was only slightly
higher than the percentages of cells that expressed
CD69 after migration the lungs of the WSN-OVA0-
infected partners (Figure 6A) which expressed the mu-
tant SIINLEKL epitope (J.A. Hollenbaugh and R.W. Dut-
ton, unpublished data). The percentage of OVA-specific
CD8 T cells that expressed CD69 after migration into the
MLN of the WSN-OVA1-infected mice was substantially
higher (12%–21%) and included some IL-7Rlow cells
(Figure 6D). These data were consistent with our earlier
conclusion that the MLN was a primary site of antigen
presentation during the chronic stage of the response.
Discussion
The possibility that low levels of antigen could be impor-
tant for sustaining protective immunity has been sug-
gested for several chronic and acute viral infections (Zin-
kernagel, 2002; Gray, 2002; Kundig et al., 1996). In this
paper, we have defined a role for residual viral antigens
in tissue-specific T cell migration to the lungs after pul-
monary influenza virus infection. We demonstrate that
processed viral antigens that are retained in the DLN
continue to be presented to CD8 T cells for at least
2 months after infection. We show that these anti-
gens control the migratory pattern and activation state
of virus-specific CD8 T cells near the site of virus
Immunity
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to secondary viral challenge. Transfer experiments were
recently used to analyze the development of CD4 mem-
ory T cells after influenza virus infection (Jelly-Gibbs
Figure 6. Pulmonary Influenza Virus Infection Is Insufficient for Sus-
tained CD8 T Cell Activation in the Lungs and MLN
WSN-OVA1-infected mice were joined to congenic CD45.1
+ partners
that had been infected with (A and B) WSN-OVA0 or (C and D) WSN-
OVA1. Three weeks after surgery, the lungs (A and C) and MLN (B and
D) were analyzed for OVA-specific CD8 T cells that expressed CD69
and IL-7R. The CD45.1 marker was used to distinguish T cells from
each animal. Gated populations of CD45.1+ or CD45.2+ OVA-specific
CD8 T cells are shown as indicated. Suture marks and arrows denote
the direction of T cell migration.et al., 2005). This study showed that viral antigens
were presented to naive CD4 T cells up to 4 weeks after
infection. Although T cell activation and migration to the
lungs were not analyzed, a small number of the trans-
ferred CD4 T cells survived to become memory T cells
after antigen stimulation, demonstrating that MHC class
II+ antigen presenting cells participated in T cell stimula-
tion and memory formation. We have extended these
studies to analyze the impact of chronic antigen stimula-
tion on the migration of virus-specific CD8 T cells near
the site of infection during the months of declining cellu-
lar immunity (Liang et al., 1994). We show that the reser-
voir of antigen-specific CD8 T cells in the lung airways is
replenished by blood-borne migrants through a dynamic
process that continues for many weeks after infection.
Replenishment of this cell population is virus specific
and dependent on the route of infection. In contrast, by-
stander CD8 memory T cells, which were recruited to the
lungs during acute influenza virus infection, were not ac-
tivated and were not retained later in the response. We
also show that the MLN and CLN were the primary sites
of antigen presentation during the chronic stage of the
response. This conclusion was supported by the parabi-
osis studies, which showed that some virus-specific
CD8 T cells upregulated CD69 when they reached the
MLN of the influenza virus-infected partners. Other mi-
grating CD8 T cells that entered the lungs of the same
animals remained CD69, indicating that they were not
responding to antigens in the lung tissues.
It is possible that the slow rate of equilibration by vi-
rus-specific CD8 T cells in the lungs of the influenza vi-
rus-infected mice during parabiosis was due, in part,
to some preferential trafficking between the MLN and
lungs of the donor animals (Figures 2 and 3A). A model
of the proposed pathway of T cell migration is shown
in Figure 7. It is known that activated CD8 T cells leave
the MLN of the infected mice in the efferent lymph, which
joins the venous blood supply at the thoracic duct. After
the first pass through the heart, the migrating T cells
reach the lungs of the donor animal in the pulmonary
circulation. Blood that returns to the heart from the pul-
monary circulation can then join the general circulation
Figure 7. Proposed Pathway of CD8 T Cell Migration in Joined Mice
Virus-specific CD8 T cells that respond to residual viral antigens in
the MLN (1) of the influenza virus-infected mice preferentially mi-
grate to the lungs of the donor animals (2) via the pulmonary circula-
tion. Activated (CD69+ IL-R2) CD8 T cells are preferentially retained
in the lung tissues of the infected mice, whereas less activated cells
pass through and rejoin the circulation (3) where they can gain ac-
cess to the lungs of the recipient animals (4).
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447and thus gain passage to the recipient partner. We sug-
gest that this indirect route of T cell migration leads to
preferential retention of activated CD8 T cells in the
lungs of the influenza virus-infected donor mice. The
precise mechanism of this retention is currently under
investigation. In contrast, less-activated T cells pass
through the lungs of the infected mice more easily and
have an increased probability of reaching the recipient
lungs. This model is compatible with the data that are
shown in Figure 4, which show that processed viral an-
tigens are not accessible to naive T cells in the lung tis-
sues. We find no evidence that activated CD8 T cells that
leave the MLN must first pass through the spleen before
reaching the lungs; however, the transfer studies in Fig-
ure 4 showed that some proliferating CD8 T cells ulti-
mately reached the spleen, which is known to be a col-
lection point for effector CD8 T cells. In future studies,
we will use parabiosis to analyze the impact of residual
antigen presentation on T cell migration after the patho-
gen has been administered by different routes of infec-
tion. Based on the data described here, we believe
that if activated T cells were generated in another part
of the body they would not collect in the lung airways
without the residual inflammation of a prior pulmonary
virus infection. Migration studies will show whether anti-
gen-specific T cells are retained in other DLN when the
infection is administered by these alternative routes.
The different rates of T cell equilibration in the lung pa-
renchyma and BAL after parabiosis indicate that distinct
mechanisms of recruitment were responsible for main-
taining the T cell populations at each location. By 2
weeks after surgery, 19% of the NP366–374/D
b-specific
CD8 T cells that were in the BAL were derived from
the partner animals. If we assume that self-derived
NP366–374/D
b-specific CD8 T cells are also recruited to
the BAL at a similar rate (which is probably a conservative
estimate), then we might expect that the entire BAL pop-
ulation would be replaced within 4–5 weeks. This is con-
siderably slower than the 10 day replacement period that
was recently calculated by using changing CD11a ex-
pression as an indirect measure of T cell migration after
Sendai virus infection (Ely et al., 2006). We also find
some CD11a bright cells in the lung airways after influ-
enza virus infection (w10% of the NP366–374/D
b-specific
cells on day 44 after infection), but not as many as the
30%–50% reported in the Sendai virus model. Different
proportions of CD11a bright cells within the partner
and self-derived NP366–374/D
b-specific CD8 T cells in
the BAL after parabiosis also indicated that some cells
entered the airways before surgery and persisted until
the end of the experiment. The different rates of T cell re-
cruitment to the lung airways in these studies indicate
that there may be important differences between the
Sendai and influenza viruses, leading to an emphasis of
different mechanisms during recruitment. Our studies in-
dicate that T cell recruitment to the lung airways stops
within a few months, when residual antigens disappear
from the DLN (data not shown). The potential influence
of residual antigen presentation on T cell activation could
not be evaluated in the Sendai virus model because TcR
transgenic mice are not available. Transferred spleen
cells only reached the lung airways of the Sendai virus-
infected mice after CpG-DNA treatment, suggesting
that resting memory T cells were probably not the pri-mary source of cells that were recruited to the BAL (Ely
et al., 2006). Others have used parabiosis to analyze
CD8 T cell migration after systemic infections (Klonowski
et al., 2004). In these studies, VSV and LM-OVA-specific
CD8 T cells equilibrated quickly in most tissues, in-
cluding the lungs, but migration to the intestinal lamina
propria was severely limited. Together, these data indi-
cate that T cell migration to mucosal tissues is regulated
by distinct mechanisms that are not present in other tis-
sues. The reduction in CD11a expression may prevent vi-
rus-specific CD8 T cells that enter the lung airways dur-
ing respiratory virus infections from returning to the
circulation (Ely et al., 2003b; Masopust et al., 2004).
In some situations, chronic presentation of T cell anti-
gens can be deleterious to immunity and result in the de-
velopment of dysfunctional memory CD8 T cell popula-
tions with poor survival characteristics (Redmond and
Sherman, 2005). However, not all chronic infections are
linked to memory T cell defects in vivo. For example,
virus-specific CD8 T cells that accumulated in the tri-
geminal ganglia after herpes simplex virus infection
maintained CD69 expression for several months in vivo
without a detectable loss of effector functions (Khanna
et al., 2003). Similarly, it has been established that virus-
specific CD8 T cells that remain in the airways after pul-
monary influenza virus infection are not anergic or termi-
nally differentiated (end-stage) effector T cells, because
these cells can proliferate and produce cytokines in vitro
and initiate recall responses after transfer to naive mice
(Hoganetal., 2001a;OstlerandEhl,2002;Ely et al., 2003b).
In a recently published study, we showed that den-
dritic cells (DC) were required to maximize the response
to secondary challenge, using three different microbial
infections, including influenza virus (Zammit et al.,
2005). Here, we have shown that naive CD8 T cells pro-
liferated in response to the antigens that were retained in
the DLN, which strongly suggests that DC play a role in
persistent antigen presentation. Infectious influenza vi-
rus can be detected in the lungs of mice for only about
10–14 days after inoculation (Liang et al., 1994). Al-
though long-term infection of the CNS has been re-
ported in immunocompromised mice (Aronsson et al.,
2001, 2002), viral RNA had dropped below the level of
detection by day 30 in wild-type animals in this and other
published studies (Hamilton-Easton and Eichelberger,
1995; Jelly-Gibbs et al., 2005). Together, these data sug-
gest that protein antigens are retained in vivo without vi-
rus amplification, although we cannot rule out the possi-
bility that very low levels of viral RNA persist in some
tissues. In support of this suggestion, a population of
antigen-bearing DC was found in the airways of mice
more than 8 weeks after aerosol inoculation with the
Leishmania LACK antigen (Julia et al., 2002). Others
have shown long-term effects of influenza virus infection
on the activation markers of DC in the lungs (Dahl et al.,
2004; Yamamoto et al., 2000).
Our data indicate that sustained antigen presentation
is required for activated CD8 T cells to be retained near
the site of infection, where they can mount a rapid re-
sponse to secondary viral challenge during heterosub-
typic infection. A detailed analysis of the antigen presen-
tation pathway that leads to chronic T cell activation in
the MLN and CLN will be required to determine which an-
tigen presenting cells are involved and whether cytosolic
Immunity
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quired. These data hold important implications for un-
derstanding pulmonary immunity and thus will impact
the design of vaccines for protection against influenza




Female C57BL/6J and congenic C57BL/6-Ly5.2 mice were pur-
chased from Charles River through the NCI animal program. The
OTI mouse line (Hogquist et al., 1994) was generously provided by
Dr. W.R. Heath (WEHI, Melbourne, Australia) and Dr. F. Carbone (Uni-
versity of Melbourne, Melbourne, Australia). Female mice at 8–12
weeks of age, were anesthetized by i.p. injection with avertin
(2,2,2-tribromoethanol) before i.n. infection with 300 50% egg infec-
tious doses (EID50) of HKx31 or E61-13-H17 influenza virus or 10
3 pfu
WSN-OVA. Virus stocks were grown in chicken eggs, titered, and
stored as described previously (Daly et al., 1995). Alternatively,
mice were given 103 CFU recombinant LM-OVA by i.v. injection and
boosted 1 month later with 104 CFU (Pope et al., 2001). ODN-DNA
was synthesized with modified phosphate bonds to prevent degra-
dation by nuclease activity (Midland Reagent Co. TX). The stimula-
tory sequence includes two embedded CpG-motifs that are marked
in bold (50-ATAATCGACGTTCAAGCAAG-30) (Schwartz et al., 1997).
Substitutions in the control sequence (50-ATAATAGAGCTTCAAG
CAAG-30) are also marked in bold. Anesthetized mice were treated
with 15 mg of ODN-DNA (in 30 ml PBS) by passive inhalation.
Sample Preparation for Flow Cytometry
Lymphocytes were collected from the lungs by lavage five times in
Hank’s balanced saline solution (HBSS). The mice were perfused
with PBS 75 U/ml heparin until the lungs were white in color. Lym-
phocytes were released from the chopped lung tissues by digestion
with 150 U/ml collagenase (Life Technologies, Rockville, MD) in
RPMI, 1 mM MgCl2, 1 mM CaCl2, and 5% FCS at 37ºC for 1 hr. Cells
were mashed through strainers and suspended in 44% isotonic Per-
coll, underlaid with 67% isotonic Percoll, and centrifuged at 4003 g
for 20 min. Lymphocytes were recovered from the interface and
washed with HBSS. Tetramers that are specific for the influenza vi-
rus NP366–374/D
b epitope have been described previously (Flynn
et al., 1998). Tetramers were supplied by the NIAID (Emory University
Vaccine Center at Yerkes, Atlanta, GA). Lymphocytes were stained
with APC-conjugated NP366–374/D
b for 1 hr at room temperature.
All other markers were stained at 4ºC with antibodies to CD45.1,
CD45.2, CD69, CD11a, and CD127 (BD Pharmingen, San Diego,
CA). Fixed samples were analyzed on a Becton-Dickenson FACSCa-
libur flow cytometer and analyzed by using FlowJo software (Tree
Star Inc.). CD8 T cells were labeled with 5 mM CFSE-dye at 37ºC
for 10 min (Lyons and Parish, 1994).
Analysis of Viral RNA by Reverse-Transcriptase
Polymerase Chain Reaction
LNs and lung tissues were ground up in 1 ml Tri Reagent (Sigma,
St Louis, MO) by using a dounce homogenizer. RNA was prepared
by using Bromochloropropane (Sigma, St Louis MO) phase separa-
tion and precipitated with isopropanol. cDNA was prepared by using
RTII superscript and random primers (Invitrogen, Carlsbad, CA). PCR
amplification of first-strand cDNA was performed for 35 cycles with
the following primers: influenza NP (50-TGATCGGAACTTCTGGAG
GG-30 and 50-TGGCCCAGTACCTGCTTCTC-30) and b-actin (50-ATG
GATGACGATATCGCTG-30 and 50-ATGAGGTAGTCTGTCAGGT-30).
Parabiosis Surgery
Parabiosis surgery was carried out as described previously (Don-
skoy and Goldschneider, 1992; Klonowski et al., 2004) in accordance
with the University of Connecticut Institutional Animal Care Commit-
tee. Incisions were made in the skin on the opposing flanks of the do-
nor and recipient animals. Surgical sutures were used to bring the
body walls of the two mice into direct physical contact. The outer
skin was then attached with surgical staples. Joined animals were
maintained for 15–21 days after surgery.Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/24/4/
439/DC1/.
Acknowledgments
The authors thank Dr. David Topham (University of Rochester) for
the WSN-OVA1 and WSN-OVA0 viruses, Dr. Jonathan Yewdell (Na-
tional Institutes of Health) for supplying the E61-13-H17 virus, and
Dr. Ulrich von Andrian (Harvard) for helpful discussion regarding
the transfer studies. In addition, we thank the National Institute of Al-
lergy and Infectious Disease tetramer facility for the antigen-specific
staining reagents and Quynh-Mai Pham for assistance with the para-
biosis surgery. This work was supported by the American Lung As-
sociation RG1119 (L.S.C.), National Institutes of Health grants
AI41576, AI0515 83, DK45260 (L.L.), and by National Institutes of
Health postdoctoral Fellowship AI053970 (K.D.K.).
Received: October 12, 2005
Revised: January 25, 2006
Accepted: January 31, 2006
Published: April 18, 2006
References
Aronsson, F., Karlsson, H., Ljunggren, H.G., and Kristensson, K.
(2001). Persistence of the influenza A/WSN/33 virus RNA at midbrain
levels of immunodefective mice. J. Neurovirol. 7, 117–124.
Aronsson, F., Lannebo, C., Paucar, M., Brask, J., Kristensson, K.,
and Karlsson, H. (2002). Persistence of viral RNA in the brain of off-
spring to mice infected with influenza A/WSN/33 virus during preg-
nancy. J. Neurovirol. 8, 353–357.
Chang, J., and Braciale, T.J. (2002). Respiratory syncytial virus infec-
tion suppresses lung CD8+ T-cell effector activity and peripheral
CD8+ T-cell memory in the respiratory tract. Nat. Med. 8, 54–60.
Dahl, M.E., Dabbagh, K., Liggitt, D., Kim, S., and Lewis, D.B. (2004).
Viral-induced T helper type 1 responses enhance allergic disease by
effects on lung dendritic cells. Nat. Immunol. 5, 337–343.
Daly, K., Nguyen, P., Woodland, D.L., and Blackman, M.A. (1995).
Immunodominance of major histocompatibility complex class I-re-
stricted influenza virus epitopes can be influenced by the T-cell re-
ceptor repertoire. J. Virol. 69, 7416–7422.
Doherty, P.C., Topham, D.J., and Tripp, R.A. (1996). Establishment
and persistence of virus-specific CD4+ and CD8+ T cell memory. Im-
munol. Rev. 150, 23–44.
Donskoy, E., and Goldschneider, I. (1992). Thymocytopoiesis is
maintained by blood-borne precursors throughout postnatal life. A
study in parabiotic mice. J. Immunol. 148, 1604–1612.
Ely, K.H., Cauley, L.S., Roberts, A.D., Brennan, J.W., Cookenham, T.,
and Woodland, D.L. (2003a). Nonspecific recruitment of memory
CD8(+) T cells to the lung airways during respiratory virus infections.
J. Immunol. 170, 1423–1429.
Ely, K.H., Roberts, A.D., and Woodland, D.L. (2003b). Cutting edge:
effector memory CD8+ T cells in the lung airways retain the potential
to mediate recall responses. J. Immunol. 171, 3338–3342.
Ely, K.H., Cookenham, T., Roberts, A.D., and Woodland, D.L. (2006).
Memory T cell populations in the lung airways are maintained by
continual recruitment. J. Immunol. 176, 537–543.
Flynn, K.J., Belz, G.T., Altman, J.D., Ahmed, R., Woodland, D.L., and
Doherty, P.C. (1998). Virus-specific CD8(+) T cells in primary and
secondary influenza pneumonia. Immunity 8, 683–691.
Gray, D. (2002). A role for antigen in the maintenance of immunolog-
ical memory. Nat. Rev. Immunol. 2, 60–65.
Hamilton-Easton, A., and Eichelberger, M. (1995). Virus-specific an-
tigen presentation by different subsets of cells from lung and medi-
astinal lymph node tissues of influenza virus-infected mice. J. Virol.
69, 6359–6366.
Hogan, R.J., Usherwood, E.J., Zhong, W., Roberts, A.A., Dutton,
R.W., Harmsen, A.G., and Woodland, D.L. (2001a). Activated
T Cell Activation and Migration in the Lung
449antigen-specific CD8+ T cells persist in the lungs following recovery
from respiratory virus infections. J. Immunol. 166, 1813–1822.
Hogan, R.J., Zhong, W.M., Usherwood, E.J., Cookenham, T., Rob-
erts, A.D., and Woodland, D.L. (2001b). Protection from respiratory
virus infections can be mediated by antigen-specific CD4(+) T cells
that persist in the lungs. J. Exp. Med. 193, 981–986.
Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan,
M.J., and Carbone, F.R. (1994). T cell receptor antagonist peptides
induce positive selection. Cell 76, 17–27.
Huster, K.M., Busch, V., Schiemann, M., Linkemann, K., Kerksiek,
K.M., Wagner, H., and Busch, D.H. (2004). Selective expression of
IL-7 receptor on memory T cells identifies early CD40L-dependent
generation of distinct CD8+ memory T cell subsets. Proc. Natl.
Acad. Sci. USA 101, 5610–5615.
Jelly-Gibbs, D.M., Brown, D.M., Dibble, J.P., Haynes, L., Eaton,
S.M., and Swain, S.L. (2005). Unexpected prolonged presentation
of influenza antigens promotes CD4 T cell memory generation.
J. Exp. Med. 202, 697–706.
Julia, V., Hessel, E.M., Malherbe, L., Glaichenhaus, N., O’Garra, A.,
and Coffman, R.L. (2002). A restricted subset of dendritic cells cap-
tures airborne antigens and remains able to activate specific T cells
long after antigen exposure. Immunity 16, 271–283.
Kaech, S.M., Tan, J.T., Wherry, E.J., Konieczny, B.T., Surh, C.D., and
Ahmed, R. (2003). Selective expression of the interleukin 7 receptor
identifies effector CD8 T cells that give rise to long-lived memory
cells. Nat. Immunol. 4, 1191–1198.
Khanna, K.M., Bonneau, R.H., Kinchington, P.R., and Hendricks,
R.L. (2003). Herpes simplex virus-specific memory CD8+ T cells
are selectively activated and retained in latently infected sensory
ganglia. Immunity 18, 593–603.
Klonowski, K.D., Williams, K.J., Marzo, A.L., Blair, D.A., Lingenheld,
E.G., and Lefrancois, L. (2004). Dynamics of blood-borne CD8 mem-
ory T cell migration in vivo. Immunity 20, 551–562.
Kranzer, K., Bauer, M., Lipford, G.B., Heeg, K., Wagner, H., and
Lang, R. (2000). CpG-oligodeoxynucleotides enhance T-cell recep-
tor-triggered interferon-gamma production and up-regulation of
CD69 via induction of antigen-presenting cell-derived interferon
type I and interleukin-12. Immunology 99, 170–178.
Kundig, T.M., Bachmann, M.F., Oehen, S., Hoffmann, U.W., Simard,
J.J., Kalberer, C.P., Pircher, H., Ohashi, P.S., Hengartner, H., and
Zinkernagel, R.M. (1996). On the role of antigen in maintaining cyto-
toxic T-cell memory. Proc. Natl. Acad. Sci. USA 93, 9716–9723.
Lang, K.S., Recher, M., Navarini, A.A., Harris, N.L., Lohning, M., Junt,
T., Probst, H.C., Hengartner, H., and Zinkernagel, R.M. (2005). In-
verse correlation between IL-7 receptor expression and CD8 T cell
exhaustion during persistent antigen stimulation. Eur. J. Immunol.
35, 738–745.
Liang, S., Mozdzanowska, K., Palladino, G., and Gerhard, W. (1994).
Heterosubtypic immunity to influenza type A virus in mice. Effector
mechanisms and their longevity. J. Immunol. 152, 1653–1661.
Lyons, A.B., and Parish, C.R. (1994). Determination of lymphocyte
division by flow cytometry. J. Immunol. Methods 171, 131–137.
Marshall, D.R., Turner, S.J., Belz, G.T., Wingo, S., Andreansky, S.,
Sangster, M.Y., Riberdy, J.M., Liu, T., Tan, M., and Doherty, P.C.
(2001). Measuring the diaspora for virus-specific CD8+ T cells.
Proc. Natl. Acad. Sci. USA 98, 6313–6318.
Masopust, D., Vezys, V., Usherwood, E.J., Cauley, L.S., Olson, S.,
Marzo, A.L., Ward, R.L., Woodland, D.L., and Lefrancois, L. (2004).
Activated primary and memory CD8 T cells migrate to nonlymphoid
tissues regardless of site of activation or tissue of origin. J. Immunol.
172, 4875–4882.
Moskophidis, D., and Kioussis, D. (1998). Contribution of virus-
specific CD8+ cytotoxic T cells to virus clearance or pathologic man-
ifestations of influenza virus infection in a T cell receptor transgenic
mouse model. J. Exp. Med. 188, 223–232.
Nguyen, H.H., Moldoveanu, Z., Novak, M.J., van Ginkel, F.W., Ban,
E., Kiyono, H., Mcghee, J.R., and Mestecky, J. (1999). Heterosub-
typic immunity to lethal influenza A virus infection is associated
with virus-specific CD8(+) cytotoxic T lymphocyte responses in-
duced in mucosa-associated tissues. Virology 254, 50–60.Nguyen, H.H., van Ginkel, F.W., Vu, H.L., Mcghee, J.R., and Mes-
tecky, J. (2001). Heterosubtypic immunity to influenza A virus infec-
tion requires B cells but not CD8+ cytotoxic T lymphocytes. J. Infect.
Dis. 183, 368–376.
Ostler, T., and Ehl, S. (2002). Pulmonary T cells induced by respira-
tory syncytial virus are functional and can make an important contri-
bution to long-lived protective immunity. Eur. J. Immunol. 32, 2562–
2569.
Ostler, T., Hussell, T., Surh, C.D., Openshaw, P., and Ehl, S. (2001).
Long-term persistence and reactivation of T cell memory in the
lung of mice infected with respiratory syncytial virus. Eur. J. Immu-
nol. 31, 2574–2582.
Pope, C., Kim, S.K., Marzo, A., Masopust, D., Williams, K., Jiang, J.,
Shen, H., and Lefrancois, L. (2001). Organ-specific regulation of the
CD8 T cell response to Listeria monocytogenes infection. J. Immu-
nol. 166, 3402–3409.
Ray, S.J., Franki, S.N., Pierce, R.H., Dimitrova, S., Koteliansky, V.,
Sprague, A.G., Doherty, P.C., De Fougerolles, A.R., and Topham,
D.J. (2004). The collagen binding alpha1beta1 integrin VLA-1 regu-
lates CD8 T cell-mediated immune protection against heterologous
influenza infection. Immunity 20, 167–179.
Redmond, W.L., and Sherman, L.A. (2005). Peripheral tolerance of
CD8 T lymphocytes. Immunity 22, 275–284.
Schluns, K.S., Kieper, W.C., Jameson, S.C., and Lefrancois, L.
(2000). Interleukin-7 mediates the homeostasis of naive and memory
CD8 T cells in vivo. Nat. Immunol. 1, 426–432.
Schwartz, D.A., Quinn, T.J., Thorne, P.S., Sayeed, S., Yi, A.K., and
Krieg, A.M. (1997). CpG motifs in bacterial DNA cause inflammation
in the lower respiratory tract. J. Clin. Invest. 100, 68–73.
Stephens, R., Randolph, D.A., Huang, G., Holtzman, M.J., and Chap-
lin, D.D. (2002). Antigen-nonspecific recruitment of Th2 cells to the
lung as a mechanism for viral infection-induced allergic asthma.
J. Immunol. 169, 5458–5467.
Sun, S., and Sprent, J. (2000). Role of type I interferons in T cell ac-
tivation induced by CpG DNA. Curr. Top. Microbiol. Immunol. 247,
107–117.
Topham, D.J., Tripp, R.A., and Doherty, P.C. (1997). CD8+ T cells
clear influenza virus by perforin or Fas-dependent processes. J. Im-
munol. 159, 5197–5200.
Topham, D.J., Castrucci, M.R., Wingo, F.S., Belz, G.T., and Doherty,
P.C. (2001). The role of antigen in the localization of naive, acutely
activated, and memory CD8(+) T cells to the lung during influenza
pneumonia. J. Immunol. 167, 6983–6990.
Townsend, A.R., and Skehel, J.J. (1984). The influenza A virus
nucleoprotein gene controls the induction of both subtype specific
and cross-reactive cytotoxic T cells. J. Exp. Med. 160, 552–563.
Townsend, A.R., Rothbard, J., Gotch, F.M., Bahadur, G., Wraith, D.,
and McMichael, A.J. (1986). The epitopes of influenza nucleoprotein
recognized by cytotoxic T lymphocytes can be defined with short
synthetic peptides. Cell 44, 959–968.
Webby, R.J., Andreansky, S., Stambas, J., Rehg, J.E., Webster,
R.G., Doherty, P.C., and Turner, S.J. (2003). Protection and compen-
sation in the influenza virus-specific CD8+ T cell response. Proc.
Natl. Acad. Sci. USA 100, 7235–7240.
Woodland, D.L., Ely, K.H., Crowe, S.R., Tighe, M., Brennan, J.W.,
Harmsen, A.G., and Cauley, L.S. (2002). Antiviral memory T-cell re-
sponses in the lung. Microbes Infect. 4, 1091–1098.
Yamamoto, N., Suzuki, S., Shirai, A., Suzuki, M., Nakazawa, M., Na-
gashima, Y., and Okubo, T. (2000). Dendritic cells are associated
with augmentation of antigen sensitization by influenza A virus infec-
tion in mice. Eur. J. Immunol. 30, 316–326.
Yewdell, J.W., and Haeryfar, S.M. (2005). Understanding presenta-
tion of viral antigens to CD8+ T cells in vivo: the key to rational vac-
cine design. Annu. Rev. Immunol. 23, 651–682.
Zammit, D.J., Cauley, L.S., Pham, Q.M., and Lefrancois, L. (2005).
Dendritic cells maximize the memory CD8 T cell response to infec-
tion. Immunity 22, 561–570.
Zinkernagel, R.M. (2002). On differences between immunity and im-
munological memory. Curr. Opin. Immunol. 14, 523–536.
